Search
for
Sort by
Research 511–540 of 535
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Can Plant Extracts Help Prevent Hair Loss or Promote Hair Growth? A Review Comparing Their Therapeutic Efficacies, Phytochemical Components, and Modulatory Targets
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Targeted immunotherapy for hair regrowth and regeneration
- mTOR signaling in hair follicle and hair diseases: recent progress
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- An Updated in the Management of Alopecia Areata
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- The potential of regulatory T cell-based therapies for alopecia areata
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Update From Dermatology Nurses’ Association Convention 2025
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- 63418 JAK3/TEC kinase pathways are active in alopecia areata lesions, and their inhibition with Ritlecitinib prevents αCD3/αCD28+IL-2 induced immune privilege collapse in healthy hair follicles ex vivo